Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL OTHER INCOME
Total Other Income HALO - Halozyme Therapeutics, Inc.
5.66 M
LAST VALUE
51.79%
2 YEAR CAGR
26.34%
5 YEAR CAGR
11.83%
10 YEAR CAGR